05.31.09 Ironwood and Forest Present Additional Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome with Constipation - Data Presented Today at DDW Demonstrate Linaclotide Provided Early Onset of Abdominal Pain Relief and Improved Bowel Habits 05.12.09 Ironwood and Forest to Present Additional Phase 2b Data for Novel Gastrointestinal Agent Linaclotide - Data to be Presented at Digestive Disease Week 2009 05.04.09 Ironwood Announces Linaclotide European Licensing Agreement with Almirall - Ironwood Will Receive Up To $55 Million in Near Term Payments